CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biology

View/ Open
Author
Keenan, Brendan T
Tang, Anna
Rosenkrantz, Laura L
Imboywa, Selina
Von Korff, Alina
Morris, Martha C
Evans, Denis A
Schneider, Julie A
Bennett, David A
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1038/nn.3435Metadata
Show full item recordCitation
Bradshaw, E. M., L. B. Chibnik, B. T. Keenan, L. Ottoboni, T. Raj, A. Tang, L. L. Rosenkrantz, et al. 2013. “CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biology.” Nature neuroscience 16 (7): 10.1038/nn.3435. doi:10.1038/nn.3435. http://dx.doi.org/10.1038/nn.3435.Abstract
In our functional dissection of the CD33 Alzheimer’s disease susceptibility locus, we find that the rs3865444C risk allele is associated with greater cell surface expression of CD33 in monocytes (t50 = 10.06, pjoint=1.3×10–13) of young and older individuals. It is also associated with (1) diminished internalization of Aβ42) (2) accumulation of neuritic amyloid pathology and fibrillar amyloid on in vivo imaging and (3), increased numbers of activated human microglia.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703870/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879590
Collections
- HMS Scholarly Articles [18305]
Contact administrator regarding this item (to report mistakes or request changes)